6533b86cfe1ef96bd12c8b3a

RESEARCH PRODUCT

Progression of untreated mild thoracic Scheuermann's kyphosis – Radiographic and functional assessment after mean follow-up of 46 years

Dietrich SchlenzkaJyrki KettunenAri HeinonenUrho M. KujalaLeena Ristolainen

subject

AdultMalemedicine.medical_specialtyTime FactorsAdolescentScheuermann's kyphosisRadiographyKyphosisScheuermann DiseasepatientsspineThoracic VertebraeYoung Adult03 medical and health sciencesGrip strength0302 clinical medicineQuality of lifeDeformitymedicineHumansScheuermanns kyfosOrthopedics and Sports MedicineRange of Motion Articularradiologi030222 orthopedicsradiographersbusiness.industryta3141Recovery of Functionfollow-up studyMiddle Agedmedicine.diseaseSurgeryRadiographymedicine.anatomical_structureThoracic vertebraeDisease ProgressionorthopedicsFemaleSurgerybehandlingsresultatmedicine.symptomRange of motionbusiness030217 neurology & neurosurgeryHamstringFollow-Up Studiestreatment methods

description

There is no data available on the radiographic development of the Scheuermann's deformity. Our purpose was to investigate radiographic deformity progression and the relation between kyphosis progression and clinical outcome in patients with untreated Scheuermann's kyphosis.Thoracic kyphosis (Th4-Th12) was measured from standing lateral radiographs in 19 patients at baseline and after mean 46-year follow-up. Mean age at baseline was 19.2 and at follow-up 64.7 years. At follow-up, height, weight, hand grip strength, and hamstring tightness were measured, and sit-to-stand and walking tests were performed. Additionally general health and quality of life questionnaires were administered.The mean thoracic kyphosis increased from 46° (range 25°-78°) at baseline to 60° (34°-82°) (p  0.001) at follow-up. Mean of the vertebrae wedge increased from 8.8° to 9.9° (p = 0.046). There was no correlation between extent of kyphosis progression and function at follow-up.Among patients with Scheuermann's disease the degree of radiographic deformity progressed slightly during long-term follow-up. Progression did not predict symptoms.

https://doi.org/10.1016/j.jos.2017.03.009